Search results for: 'bioprocessing, bioreactor'

The Transformational Health team at Frost & Sullivan provides critical insights into the US and EU upstream bioprocessing market, highlighting drug demand trends, installed capacity developments, market revenue forecast by various segments, competitive landscape, and key growth opportunities that currently exist or are set to develop during the for...

08 Jun 2021  |  North America  |  Market Research

Global Decentralized Containerized/Packaged Water and Wastewater Treatment Systems Growth Opportunities

Circular Economy Policies and Renewable Energy Fuel Decentralized Solutions Adoption

Infographics

×

Water stress and rapid urbanization worldwide impact water and sanitation coverage, especially among economically vulnerable populations in developing and under-developed countries. Water quality and sanitation are a primary concern in developed nations and part of their sustainability and circular economy policies. Centralized water and wastewater...

The growth trajectory of the global life sciences industry has benefited from a combination of novel technologies such as CRISPR-Cas9, microbiome and single-cell, relaxation of entry barriers in markets like China, and better-defined regulatory frameworks around next-generation therapies and companion diagnostics. A common denominator of growth a...

Overall Impact of Biomanufacturing Technology Innovations Impact on Unmet Needs Pharmaceutical companies perceive analytical services as important. There is a need for a robust platform that enables the provision of such services. Pharma firms are outsourcing crucial processes and are utilizing services such as analytics, research, process developm...

This research service on the global nutraceutical ingredients market provides the following analysis: • Market revenue forecasts (in USD billion), global and regional • Growth opportunities and insights on the competitive landscape • Discussion of the major factors influencing market growth Among the most commonly used and recognized cat...

The COVID-19 pandemic led to the rapid scaling up of production activities in the pharmaceutical industry. An increase in the number of FDA approvals in biologics has further accelerated biopharmaceutical production, particularly in North America and Asia. With a boom in biopharmaceuticals anticipated in the next 5 to 7 years, the demand for single...